| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 24.013 | 83.047 | 120.778 | 159.113 | 202.783 |
| Total Income - EUR | - | - | - | - | - | 24.013 | 83.047 | 120.781 | 159.115 | 202.785 |
| Total Expenses - EUR | - | - | - | - | - | 6.537 | 27.352 | 32.201 | 40.468 | 38.382 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 17.476 | 55.695 | 88.580 | 118.646 | 164.403 |
| Net Profit/Loss - EUR | - | - | - | - | - | 17.236 | 54.964 | 87.433 | 117.278 | 159.232 |
| Employees | - | - | - | - | - | 1 | 1 | 2 | 2 | 2 |
Check the financial reports for the company - Marinescu Angiolife S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 134 | 76.586 | 75.617 | 74.560 | 71.147 |
| Current Assets | - | - | - | - | - | 17.838 | 40.676 | 47.782 | 64.676 | 97.937 |
| Inventories | - | - | - | - | - | 645 | 1.008 | 1.011 | 2.261 | 2.540 |
| Receivables | - | - | - | - | - | 0 | 5.070 | 25.771 | 5.579 | 58.390 |
| Cash | - | - | - | - | - | 17.193 | 34.598 | 21.000 | 56.836 | 37.006 |
| Shareholders Funds | - | - | - | - | - | 17.277 | 71.859 | 87.528 | 117.373 | 159.398 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 695 | 45.404 | 35.871 | 21.863 | 9.686 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Marinescu Angiolife S.r.l.